Investigation of the Effects of Sleep Deprivation on Itch and Pain Sensitivity

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAalborg University

About this trial

In This experiment, the investigators would like to test following hypotheses regarding the influence of sleep deprivation on itch:

* To investigate similarity and differences between itch and pain by comparing the effect of sleep deprivation in them. * To evaluate the inflammatory state induced by sleep fragmentation via the analysis of C-reactive protein (CRP) levels from blood samples. * To correlate the anxiety and depression scores (evaluated through questionnaires) with itch and pain sensitivity and evaluate how they are affected by sleep. In This experiment, the investigators would like to test following hypotheses regarding the influence of sleep fragmentation on itch: * To investigate similarity and differences between itch and pain by comparing the effect of sleep deprivation in them. * To evaluate the inflammatory state induced by sleep fragmentation via the analysis of C-reactive protein (CRP) levels from blood samples. * To correlate the anxiety and depression scores (evaluated through questionnaires) with itch and pain sensitivity and evaluate how they are affected by sleep deprivation.

Eligibility criteria

Qualifiers

Healthy men and women

18-60 years

Speak and understand English

Access to a smartphone during the experimental nights

Disqualifiers

Pregnancy or lactation

Drug addiction defined as any use of cannabis, opioids, or other drugs

Previous or current history of neurological, dermatological, immunological musculoskeletal, cardiac disorder or mental illnesses (psychiatric diagnosis) that may affect the results (e.g., neuropathy, muscular pain in the upper extremities, anxiety, depression, schizophrenia etc.)

Moles, wounds, scars, or tattoos in the area to be treated or tested

Trial design

Treatments tested in this trial

  • Histamine
  • Cowhage

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators